the development of innovative healthcare. Over 39,000 employees worldwide
are dedicated to the discovery, production and marketing of breakthrough drugs.
These treat diabetes, cancer, sepsis, osteoporosis, erectile dysfunction,
cardiovascular disease, disorders of the central nervous system and infectious diseases. In 2010 we invested roughly 5 billion US-$ in research and development.
Our European Statistics team works on a wide variety of projects covering early and late phases of drug development and market access. The European Statistics team provides innovative scientific and operational excellence in design, analysis, and interpretation in order to convert scientific information to knowledge that is useful to consumers and patients. The team is located on different sites across Europe.
We have
been growing continuously for years. So why not grow with us?